ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Costimulation Blockade by Anti CD40 Antibody Prevents Humoral and Cellular Rejection of Heterotopic Pig Cardiac Xenograft.

A. Singh,1 J. Chan,1 P. Corcoran,1 B. Lewis,2 M. Thomas,2 D. Ayares,3 K. Horvath,1 M. Mohiuddin.1

1CSRP/NHLBI, NIH, Bethesda, MD
2DVR/ORS, NIH, Bethesda, MD
3Revivicor Inc., Blacksburg, VA.

Meeting: 2016 American Transplant Congress

Abstract number: 362

Keywords: Co-stimulation, Heart/lung transplantation, Immunosuppression, Xenotransplantation

Session Information

Date: Monday, June 13, 2016

Session Name: Concurrent Session: Xenotransplantation: Animal Models

Session Time: 4:30pm-6:00pm

 Presentation Time: 4:54pm-5:06pm

Location: Room 102

Related Abstracts
  • Complication Free Heterotopic Cardiac Xenograft Survival by Anti CD40 Antibody Mediated Co-Stimulation Blockade
  • Long Term Heterotopic Cardiac Xenograft Survival from Donor Pigs with Six Gene Modifications.

Background

Xenotransplantation (XTx) involves the participation of innate immune system with natural antibody producing B cells, NK cells, macrophages and complement as well as adaptive immune system from T and B cells. Recently we have reported cardiac xenograft survival of over 2.5 years in a pig-to-baboon heterotopic transplantation model using a modified immunosuppression (IS) regimen, which includes depletion B cells and costimulation blockade by anti-CD40 antibody. In this study we demonstrate that continuous treatment of high dose of anti-CD40 antibody could prevent the xenograft rejection.

Methods

Heterotopic cardiac XTx was performed from GTKO.hCD46Tg (n=8) and GTKO.hCD46.hTBM (n=5) GE pigs into baboons using IS regimen that included ATG, anti-CD20 antibody, MMF, CVF, and co-stimulation blockade (anti-CD154 or anti-CD40) antibody. Telemetry, palpation and ultrasound (U/S) were used to evaluate the xenograft function. Baboon peripheral blood lymphocytes (PBLs) and serum were collected twice a week for the first two months post XTx and then monthly thereafter. Mixed lymphocyte reaction (MLR) and flow cytometry analysis was performed on PBLs to analyze the T cell response and the relative percentages of the B and T cells subsets. Non-gal IgG and IgM antibodies were measured in serum using their binding to pig endothelial cells (PAECs). Antibody secretion from stimulated PBLs of recipient baboon was also measured by ELISA.

Results and Conclusion

The GE pig cardiac xenografts along with modified IS (either anti- CD154 or CD40 antibody) survived up to 945 day.In MLR in-vitro T and B cells immune response was suppressed. The non-gal IgG and IgM antibodies were inhibited in long-term survivors. Regulatory T cell numbers were also maintained. After one and half or two year , anti-CD40 antibody was withdrawn from long-term xenograft survivors (n=2), which resulted in rejection of GE pig hearts over 8-10 week period. During this period serum levels of non-gal antibodies were progressively increased. These results demonstrate that the costimulation blockade by anti-CD40 antibody effectively suppresses adaptive immune response and xenograft rejection of GE pig hearts.

CITATION INFORMATION: Singh A, Chan J, Corcoran P, Lewis B, Thomas M, Ayares D, Horvath K, Mohiuddin M. Costimulation Blockade by Anti CD40 Antibody Prevents Humoral and Cellular Rejection of Heterotopic Pig Cardiac Xenograft. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Singh A, Chan J, Corcoran P, Lewis B, Thomas M, Ayares D, Horvath K, Mohiuddin M. Costimulation Blockade by Anti CD40 Antibody Prevents Humoral and Cellular Rejection of Heterotopic Pig Cardiac Xenograft. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/costimulation-blockade-by-anti-cd40-antibody-prevents-humoral-and-cellular-rejection-of-heterotopic-pig-cardiac-xenograft/. Accessed February 25, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Left-Sided Donor Nephrectomy Predisposes Living Kidney Donors to Latent Adrenal Insufficiency with Symptoms of Fatigue and Inferior Quality of Life.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.